 |
인쇄하기
취소
|
Green Cross becomes largest shareholder of Innocell
Green Cross Corp. recently purchased 23.43 percent in shares of Innocell, a Korean cell therapeutics company.
The company announced Thursday in a regulatory filing that it acquired Innocell as the largest shareholder to increase its managerial control over the biopharmaceutical firm.
The equity of Biomedical Holdings was lowered from 5.53 percent to 4.24 percent.
Jung Hyun-jin, a docto...
The company announced Thursday in a regulatory filing that it acquired Innocell as the largest shareholder to increase its managerial control over the biopharmaceutical firm.
The equity of Biomedical Holdings was lowered from 5.53 percent to 4.24 percent.
Jung Hyun-jin, a docto...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.